Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 15

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 15
---
)Consist of 1,929,015shares of common stock purchased in the Private Placement by S.H.N Financial Investments Ltd (“S.H.N”) and excludes 1,929,015shares of common stock (subject to the adjustment and alternative cashless exercise provisions of the Series A Warrants) issuable upon the exercise of the Series A Warrants held by S.H.N, the exercise of which are subject to receipt of the Warrant Stockholder Approval and certain beneficial ownership limitations. Nir Shamir and Hadar Shamir have shared power to vote and dispose of the securities held by S.H.N and may be deemed to be the beneficial owners of such shares of common stock. The business address of S.H.N is Arik Einstein 3, Herzliya, Israel. (10)Consist of 1,929,015shares of common stock purchased in the Private Placement by Great Point Capital, LLC (“Great Point”) and excludes 1,929,015shares of common stock (subject to the adjustment and alternative cashless exercise provisions of the Series A Warrants) issuable upon the exercise of the Series A Warrants held by Great Point, the exercise of which are subject to receipt of the Warrant Stockholder Approval and certain beneficial ownership limitations. Dan Dimiero is the Manager of Great Point Capital and may be deemed to beneficially own the securities held by it. The principal address of Great Point Capital is 200 West Jackson, Ste 1000, Chicago, IL 60606. 9 Proposal No. 1 APPROVAL OF THE ISSUANCE PROPOSAL Background On March 10, 2025, we consummated the previously announced private placement (the “Private Placement”) pursuant to securities purchase agreements (“Purchase Agreements”) with certain institutional investors for the purchase and sale of an aggregate of 9,687,045shares of our common stock at a price of $1.08 per share of common stock, pre -fundedwarrants (the “Pre -FundedWarrants”) to purchase up to 1,887,045shares of our common stock (the “Pre -FundedWarrant Shares”) at a price of $1.0799 per Pre -FundedWarrant and Series A common stock warrants (the “Series A Warrants” and together with the Pre -FundedWarrants, the “Warrants”) to purchase up to 11,574,090shares of our common stock, subject to adjustment as described therein to up to an aggregate of